Last updated on July 2018

Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy


Brief description of study

Study E7389-M044-504 is an observational, post-authorization, single-arm, prospective, multicenter cohort study conducted to characterize and determine the incidence of eribulin-induced peripheral neuropathy (PN), and the frequency and time to resolution of eribulin-induced PN in participants treated with eribulin in a real-life setting for locally advanced or metastatic breast cancer following one or two prior chemotherapeutic regimens for advanced disease.

Clinical Study Identifier: NCT03027245

Find a site near you

Start Over

Eisai Trial Site 1

Oberhausen, Germany
  Connect »

Eisai Trial Site 1

Essen, Germany
6.95miles
  Connect »

Eisai Trial Site 1

Gelsenkirchen, Germany
9.66miles
  Connect »